Examining the impact of the COVID-19 pandemic on hospital-associated Clostridioides difficile infection
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2024.128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Michael J Ray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oregon State University College of Pharmacy, Department of Pharmacy Practice, Portland, OR, USA. Hauptthemen laut MEDLINE: COVID-19, Clostridium Infections, Cross Infection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
To evaluate the impact of changes in the size and characteristics of the hospitalized patient population during the COVID-19 pandemic on the incidence of hospital-associated Clostridioides difficile infection (HA-CDI).
Design
Interrupted time-series analysis.
Setting
A 576-bed academic medical center in Portland, Oregon.
Methods
We established March 23, 2020 as our pandemic onset and included 24 pre-pandemic and 24 pandemic-era 30-day intervals. We built an autoregressive segmented regression model to evaluate immediate and gradual changes in HA-CDI rate during the pandemic while controlling for changes in known CDI risk factors.
Results
We observed 4.5 HA-CDI cases per 10,000 patient-days in the two years prior to the pandemic and 4.7 cases per 10,000 patient-days in the first two years of the pandemic. According to our adjusted segmented regression model, there were neither significant changes in HA-CDI rate at the onset of the pandemic (level-change coefficient = 0.70, P -value = 0.57) nor overtime during the pandemic (slope-change coefficient = 0.003, P -value = 0.97). We observed significant increases in frequency and intensity of antibiotic use, time at risk, comorbidities, and patient age before and after the pandemic onset. Frequency of C. difficile testing did not significantly change during the pandemic ( P = 0.72).
Conclusions
Despite large increases in several CDI risk factors, we did not observe the expected corresponding changes in HA-CDI rate during the first two years of the COVID-19 pandemic. We hypothesize that infection prevention measures responding to COVID-19 played a role in CDI prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Oregon State University College of Pharmacy, Department of Pharmacy Practice, Portland, OR, USA.
- Oregon Health & Science University-Portland State University School of Public Health, Portland, OR, USA.
- Oregon Health & Science University School of Medicine, Division of Infectious Diseases, Portland, OR, USA.
- Washington State University Allen School for Global Health, Pullman, WA, USA.
ORCID-Profile: Michael J Ray, Luke C Strnad
Förderung
- NIGMS NIH HHS
Zitieren
APA
Ray, M. J., Furuno, J. P., Strnad, L. C., Lofgren, E. T., & McGregor, J. C. (2024). Examining the impact of the COVID-19 pandemic on hospital-associated Clostridioides difficile infection. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.128
Vancouver
Ray MJ, Furuno JP, Strnad LC, Lofgren ET, McGregor JC. Examining the impact of the COVID-19 pandemic on hospital-associated Clostridioides difficile infection. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2024.128
BibTeX
@article{Ray2024,
author = {Ray, Michael J and Furuno, Jon P and Strnad, Luke C and Lofgren, Eric T and McGregor, Jessina C},
title = {Examining the impact of the COVID-19 pandemic on hospital-associated Clostridioides difficile infection},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2024.128}
}
EUVIMED